StemGen, Inc. SGNI
OTC PK
| 03/31/2022 | 12/31/2021 | 09/30/2021 | |||
|---|---|---|---|---|---|
| Revenue | -- | 33.33% | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | 33.33% | -- | ||
| Cost of Revenue | -17.65% | 124.56% | -- | ||
| Gross Profit | 17.65% | -22.58% | -- | ||
| SG&A Expenses | 350.15% | -25.96% | 146.79% | ||
| Depreciation & Amortization | -3.72% | 0.00% | 31.16% | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 200.52% | -4.57% | 36.44% | ||
| Operating Income | -200.52% | 16.32% | -108.10% | ||
| Income Before Tax | -89.21% | 29.09% | -56.86% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -89.21% | 29.09% | -56.86% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -89.21% | 29.09% | -56.86% | ||
| EBIT | -200.52% | 16.32% | -108.10% | ||
| EBITDA | -300.26% | 27.03% | -141.38% | ||
| EPS Basic | -86.36% | 28.00% | -57.89% | ||
| Normalized Basic EPS | -123.08% | 8.33% | -58.33% | ||
| EPS Diluted | -86.36% | 28.00% | -57.89% | ||
| Normalized Diluted EPS | -123.08% | 8.33% | -58.33% | ||
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.01% | ||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.01% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||